Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:45:52.371Z.
Calculation as of: 2026-10-06T15:45:52.371Z.
Quote observation: 2026-10-06T15:45:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 16291309013886a388882617e5d80f34fb5e9972494eca64a5e5fc74bed8c75f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Benitec Biopharma Inc.
Market Cap
$303.53M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$297.62M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$309.62M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.97M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$290.79M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$289.25M
Free Cash Flow Yield
N/A
TTM Avg
2.65%
3Y Avg
2.65%
5Y Avg
2.65%
Market Cap
$285.94M
Free Cash Flow Yield
N/A
TTM Avg
41.16%
3Y Avg
41.16%
5Y Avg
41.16%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | $303.53M | N/A | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $297.62M | N/A | N/A | N/A | N/A |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $309.62M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $290.97M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $290.79M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $289.25M | N/A | 2.65% | 2.65% | 2.65% |
| Avita Medical Inc. (RCEL)vs › | $318.73M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.94M | N/A | 41.16% | 41.16% | 41.16% |
| CapsoVision, Inc. (CV)vs › | $319.27M | N/A | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $321.20M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
